Executive Reshuffle At Envigo
Envigo has appointed Dr Adrian Hardy president and CEO, succeeding Brian Cass, who will become executive chair, whilst Andrew Baker will become chair emeritus. Cass joined the research services provider as managing director in 1998, and was appointed CEO in 2014. Hardy has been with the company since 2002, in which time he has held a number of roles of increasing responsibility, most recently serving as chief operating officer.
You may also be interested in...
The company said its own calculations suggested a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
New Chief Technology Officers named at Seres Therapeutics, ERYTech Pharma and Adicet Bio
Swiss biotech Molecular Partners will receive upfront payment of CHF60m, including equity.